冷冻中的未来与恐惧:丹麦女性接受卵巢组织冷冻保存与移植的经历
该定性研究通过对2003年至2018年间接受卵巢组织冷冻保存的42名丹麦女性(其中32人已行卵巢组织移植)进行半结构化访谈,探讨其对冷冻保存与移植、长期储存及剩余组织使用的体验与反思。研究发现该技术带来希望与生育可能,也引发对激素敏感性癌症及再移植恶性细胞风险的担忧,并强调癌症治疗后需提供专业信息、随访与生育咨询。
要点
- 卵巢组织冷冻保存带来以未来为导向的希望与生育可能,但也伴随对激素敏感性癌症及再移植恶性细胞风险的担忧。
- 女性对卵巢组织冷冻保存程序及其前景的了解与信息获取途径,影响其对待冻存组织储存与移植的方式。
- 冻存卵巢组织被赋予超越生育的潜在价值,如恢复激素周期及对未来可能发现的想象,影响捐赠与销毁的反思。
核心结论
- 与卵母细胞和胚胎冷冻相比,卵巢组织冷冻保存是一种「希望技术」,但卵巢组织与风险和疾病相互交织,并被定位为超越生育范围的资产。
- 本研究强调卵巢组织冷冻保存及癌症治疗后需提供专业信息、随访与生育咨询。
研究设计与样本
- 对2003年至2018年间接受卵巢组织冷冻保存的42名丹麦女性进行半结构化定性访谈,其中32人接受了卵巢组织移植。
主要发现
- 总体而言,卵巢组织冷冻保存与以未来为导向的希望和生育可能相关的积极体验相联系。
- 卵巢组织冷冻保存也产生了一系列担忧,尤其涉及激素敏感性癌症和再移植恶性细胞的风险。
- 女性对卵巢组织冷冻保存程序及其前景的理解和信息获取,影响其对待冻存组织储存和移植的方式。
- 访谈显示,冻存卵巢组织还被赋予超越生育范围的潜在价值,既作为恢复激素周期的手段,也体现在对未来可能发现的想象中,影响女性对捐赠和销毁的反思。
临床怎么用
- 原文未据此给出推荐,作者在结论中强调卵巢组织冷冻保存及癌症治疗后需提供专业信息、随访与生育咨询。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Ovarian tissue cryopreservation (OTC) and subsequent re-transplantation is gaining ground as a valid technique to preserve fertility in patients facing imminent cancer treatment. This study explores patients' experiences with OTC and transplantation, including their reflections on long-term storage of tissue and the use of surplus tissue. DESIGN: Semi-structured qualitative interviews with 42 Danish women undergoing OTC between 2003 and 2018, 32 of whom had ovarian tissue transplanted. RESULTS: Overall, OTC was associated with positive experiences linked to the production of future-oriented hope and reproductive possibilities. It also generated a range of worries, particularly regarding hormone-sensitive cancers and the risk of re-transplanting malignant cells, and the women's arduous journeys to conceive after cancer resonated through the accounts. Moreover, the women's understanding of, and access to, information about the OTC procedure and its prospects affected the ways in which they approached storage and transplantation of their frozen tissue. Finally, the interviews showed how the stored ovarian tissue was also infused with potentiality beyond the scope of reproduction, both as a remedy to restore hormonal cycles and in the imagination of the-yet-to-be-discovered potential informing the women's reflections on donation and destruction. CONCLUSION: Although OTC is a 'hope technology' compared with freezing of oocytes and embryos, ovarian tissue is interlinked with risk and disease and positioned as an asset beyond the scope of reproduction. Importantly, this study underscores the need for provision of specialized information, follow-up, and fertility counselling after OTC and cancer treatment.
引用
- Bach AS, Macklon KT, Kristensen SG, et al. Futures and fears in the freezer: Danish women's experiences with ovarian tissue cryopreservation and transplantation. Reprod Biomed Online. 2020. PMID: 32736871. doi:10.1016/j.rbmo.2020.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。